LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Míreanna comhchosúla

• LMO2 and gene therapy for severe combined immunodeficiency.
  de réir: Fischer, A, et al.
  Foilsithe / Cruthaithe: (2004)
• Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
  de réir: Sabine Charrier, et al.
  Foilsithe / Cruthaithe: (2019-12-01)
• Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
  de réir: McCormack, M, et al.
  Foilsithe / Cruthaithe: (2004)
• Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model
  de réir: Guillaume Sarrabayrouse, et al.
  Foilsithe / Cruthaithe: (2025-01-01)
• A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?
  de réir: Alain E. Andrea, et al.
  Foilsithe / Cruthaithe: (2024-10-01)